PEL

Nicholas Piramal India Ltd. has informed the Exchange that Mr. Vijay Shah, Director of the Company has sold 65,000 shares of Nicholas Piramal India Ltd. on December 19, 2005. The mode of sale is through Market and the shareholding of Mr. Vijay Shah after the said sale is 2,31,397 shares of Nicholas Piramal India Ltd.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. Vijay Shah, Director of the Company has sold 26,272 shares of Nicholas Piramal India Ltd. on December 15, 2005. The mode of sale is through Market and the shareholding of Mr. Vijay Shah after the said sale is 2,96,397 shares of Nicholas Piramal India Ltd.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. J. C. Saigal, Officer of the Company has sold 60,000 shares of Nicholas Piramal India Ltd. as follows: (1) 30,000 shares on November 29, 2005. (2) 30,000 shares on December 01, 2005. The mode of sale is through Market and the shareholding of Mr. J. C. Saigal after the said sale is 53,530 shares of Nicholas Piramal India Ltd.

Nicholas Piramal India Ltd. has informed the Exchange that Dr. Maneesh Nerurkar, Officer of the Company has acquired 7500 shares of Nicholas Piramal India Ltd. on December 07, 2005. The mode of acquisition is through ESOP and the shareholding of Dr. Maneesh Nerurkar after the said acquisition is 7500 shares of Nicholas Piramal India Ltd.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. A. K. Bhat, Officer of the Company has sold 1500 shares of Nicholas Piramal India Ltd. on December 08, 2005, December 09, 2005, and December 12, 2005. The mode of sale is through Market and the shareholding of Mr. A. K. Bhat after the said sale is 8000 shares of Nicholas Piramal India Ltd.

Nicholas Piramal India Ltd. has informed the Exchange that Praneet Singh, Officer of the Company, has acquired / sold shares of Nicholas Piramal India Limited as follows: (1) Acquired 47250 shares on December 07, 2005 and (2) Sold 47250 shares on December 07, 2005. The mode of acquisition / sale is ESOP* and the shareholding of Praneet Singh after the said acquisition / sale is Nil shares of Nicholas Piramal India Ltd. *The above shares represent shares sold through cashless exercise of ESOP, whereby the shares are directly sold by the ESOP Trust on behalf of the Employee on vesting and exerci

Nicholas Piramal India Ltd. has informed the Exchange that Mr. A. K. Bhat, Officer of the Company has sold 500 shares of Nicholas Piramal India Ltd. on December 02, 2005. The mode of sale is through Market and the shareholding of Mr. A. K. Bhat after the said sale is 9,500 shares of Nicholas Piramal India Ltd.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. A. K. Bhat, Officer of the Company has sold 1,800 shares of Nicholas Piramal India Ltd. on November 25, 2005, November 26, 2005 and November 28, 2005. The mode of sale is through Market sale and the shareholding of Mr. A. K. Bhat after the said sale is 10,000 shares of Nicholas Piramal India Ltd.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. A. K. Bhat, Officer of the Company has sold 1,564 shares of Nicholas Piramal India Ltd. on November 21, 2005. The mode of sale is through Market sale and the shareholding of Mr. A. K. Bhat after the said sale is 11,800 shares of Nicholas Piramal India Ltd.

Nicholas Piramal India Ltd. has informed the Exchange that Vijay Shah, Director of the Company, has sold 68,500 shares of Nicholas Piramal India Ltd on November 23, 2005 and November 24, 2005. The mode of sale is Market sale and the shareholding of Vijay Shah after the said sale is 3,22,669 shares aggregating to 0.154% of Nicholas Piramal India Ltd.

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated November 24, 2005, issued by the Company in connection with the signing of a long-term Manufacturing and Supply Agreement with a large global hospital products company. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Clarification of News : The press had reports on November 15, 2005 that Nicholas Piramal India Limited may acquire Germany's generic firm betapharm Arzneimittel. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Nicholas Piramal India Ltd. has vide its letter inter-alia stated, "In this regard, we wish to clarify that the Company explores various strategic moves from time to time. However, as a policy and in the inte

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release being issued by the Company in connection with the acquisition of Avecia Pharmaceuticals Ltd (U.K) and its group company Torcan Chemical Ltd (Canada). The details of the press release dated October 27,2005 titled, "Nicholas Piramal acquires Avecia Pharmaceuticals, UK for a consideration of GBP 9.5 million", shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release being issued by the Company in connection with the development and know-how agreement signed with AstraZeneca. A press release with regards to the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Nicholas Piramal India Ltd. has informed the Exchange that Mr. Keki Dadiseth has been appointed on October 20, 2005 as a Director on the Board of the Company.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. A. K. Bhat, Officer of the Company has, 1) sold 500 shares of the Company on October 05, 2005. The mode of sale is through Market and the shareholding of Mr. A. K. Bhat after the said sale is 1364 shares of the Company. 2) Acquired 12,000 shares of the Company on October 13, 2005. The mode of acquisition is through ESOP and the shareholding of Mr. A. K. Bhat after the said acquisition is 13364 shares of the Company.

Nicholas Piramal India Ltd. has informed the Exchange that the total Promoter shareholding has increased from 50.70% (pre-issue) to 50.87 %( post issue). As such, the change does not exceed 2% of the total shareholding in the Company. The date of acquisition of shares is September 29, 2005 and the mode of acquisition is right issue. Company has further informed that this may be taken as disclosure by the individual constituents of the promoter Group, viz.Mr. Ajay G. Piramal. Dr.(Mrs).Swati A. Piramal, Mrs. Urvi A.Piramal and Mr.Harsh Piramal, who are also on the Board of the Company. The detai

Nicholas Piramal India Ltd. has informed the Exchange that Mr. N.B. Gad, Officer of the Company, has acquired 10,000 shares of Nicholas Piramal India Limited on October 13, 2005. The mode of acquisition is ESOP and the shareholding of Mr. N.B. Gad after the said acquisition is 10,000 shares of Nicholas Piramal India Ltd.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. J.C. Saigal, Officer of the Company, has sold 25,000 shares of Nicholas Piramal India Limited on September 26, 2005. The mode of sale is Market sale and the shareholding of Mr. J.C. Saigal after the said sale is 58,500 shares of Nicholas Piramal India Ltd..

Nicholas Piramal India Ltd. has informed the Exchange that Mr. N. Santhanam, Officer of the Company, has (1) Acquired 3,750 shares of the Company on September 29, 2005. The mode of acquisition is Rights Issue. (2) Sold 30,000 shares of the Company on September 30, 2005. The mode of sale is Market sale and (3) Acquired 30,000 shares of the Company on September 30, 2005. The mode of acquisition is ESOP. The shareholding of Mr. N. Santhanam after the said acquisition / sale is 41,250 shares of Nicholas Piramal India Ltd..

Nicholas Piramal India Ltd. has informed the Exchange that Mr. Somesh Sharma, has acquired 1,00,000 shares of Nicholas Piramal India Limited on August 24,2005. The mode of acquisition is ESOP and the shareholding of Mr. Somesh Sharma after the said acquisition is 1,00,000 shares of Nicholas Piramal India Ltd..

Nicholas Piramal India Ltd. has informed the Exchange that Mr. Somesh Sharma, officer of the company has sold 25000 shares of Nicholas Piramal India Limited on August 12,2005. The shareholding of Mr. Somesh Sharma after the said sale is NIL shares of the company. The company has further informed that the above shares represent shares sold through cashless exercise of ESOP, whereby the shares are directly sold by the ESOP Trust on behalf of the Employee on vesting and exercise thereof.

Nicholas Piramal India Ltd. had informed the Exchange regarding the proposal for investment of Can$ 6 million in the share capital of BioSyntech, Canada, subject to requisite RBI approvals. The Company has now informed that the private placement of 7,500,000 common shares at a price of Canadian $0.80 per share aggregating to Can$ 6 million in BioSyntech, Canada has been completed. The details of the press release issued in this regard shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncemen

Kotak Mahindra Capital Company Limited has informed the Exchange that with regards to the Rights Issue of Equity Shares ("ISSUE") by Nicholas Piramal India Limited, the said issue closed for subsription on August 30, 2005 as scheduled.

Nicholas Piramal India Ltd. has informed the Exchange that Vijay Shah has sold 25,000 shares of the Company on August 22, 2005. The shareholding of Vijay Shah after the said sale is 352795 shares of the Company.

Nicholas Piramal India Ltd. has informed the Exchange that one of the promoter group entities, viz. "Piramal Enterprises Limited, Trustees of the Piramal Enterprises Executive Trust" ("PEL Trust") has transferred by way of gift (i.e. without any consideration), 16,50,000 equity shares of Rs. 2 each of the Company (forming 0.86% of the pre-Issue capital of the Company) to the other Trust, namely, The Ajay G. Piramal Foundation, which is a public charitable Trust. Consequent to the said transfer, the shareholding of the PEL Trust has been reduced to 13,88,550 shares of Rs. 2 each.

Nicholas Piramal India Ltd. has informed the Exchange that at the AGM of the Company held on July 07, 2005, all the business mentioned in the Notice convening the said meeting were transacted and all the resolutions were passed with requisite majority. A brief summary of the outcome of the AGM shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Nicholas Piramal India Ltd. has informed the Exchange regarding a Press Release, dated, July 29, 2005, titled "Nicholas Piramal Q1FY06 Net Sales up 8.8%; PAT up 11.1%- Domestic Formulations grow 14.1%, Exports up 49.3%. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Nicholas Piramal India Ltd. has informed the Exchange that K J Shetty has sold 2,500 shares of the Company on July 06, 2005. The shareholding of K J Shetty after the said sale is 5,000 shares of the Company.

Nicholas Piramal India Ltd. has informed the Exchange that the Right Issue of the Company will open on August 01, 2005 and Close on August 30, 2005.

Nicholas Piramal India Ltd. has informed the Exchange regarding a Press Release, dated, July 14, 2005, titled "Nicholas Piramal announces commencement of Phase I/II clinical studies on oncology lead research molecule P276-00.". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Nicholas Piramal India Ltd. has submitted to the Exchange a copy of the press release being issued by the Company, relating to investment of Can$ 6 million in the equity shares of Biosyntech Inc., which has been approved at the Board Meeting held on July 07, 2005, subject to requisite RBI approvals. Biosyntech is a Canada-based biotechnology research company that specializes in the discovery, development and manufacture of innovative, cost-effective biologic implants for regenerative medicine and therapeutic delivery. A copy of the press release shall be available on the NSE website (http://ww

Nicholas Piramal India Ltd. has informed the Exchange that Deepak Kanvinde has sold 2,500 shares of Nicholas Piramal India Ltd. on June 07, 2005 and his shareholding after the said sale is 5,000 shares of the Company.

Nicholas Piramal India Ltd. has informed the Exchange that at the meeting of the Committee of Directors held on June 09, 2005, the Committee has approved the Issue Price at Rs.175 per share. Accordingly, the Rights Issue would comprise of 1,90,01,600 equity shares of Rs.2 each at a premium of Rs.173 per share aggregating to Rs.332.53 crores to be issued in the ratio of 1:10 i.e. one Rights equity share for every 10 existing equity shares.

Nicholas Piramal India Ltd. had informed the Exchange regarding offer price of Rs.175 per share for the rights issue of the company. The company has now informed that owing to typographical error, the total number of shares was mentioned as 1,90,01,600 whereas it should be 1,90,01,601.Therefore the total number of shares comprised in the Rights Issue should be read as 1,90,01,601 equity shares.

Nicholas Piramal India Ltd. has informed the Exchange that the Issue Price at which the equity shares would be offered for subscription under the proposed Rights Issue ("the Issue Price") would be determined by the duly constituted Committee of Directors (Rights Issue) on June 09, 2005.

Nicholas Piramal India Ltd. has informed the Exchange that the Company has announced the Book Closure from July 01, 2005 to July 07, 2005, for the following purpose: (1) Equity Shares of Rs.2/- each - For the purpose of determining (a) entitlement of equity shareholders for subscribing to the equity shares under the proposed Rights Issue. The ratio for the Rights Issue is 1:10 (i.e. one equity share for every 10 equity shares held by the shareholder); and (b) entitlement for equity dividend. (2) 5% - Preference Shares of Rs.100/- each - For the purpose of determining entitlement for preference

Nicholas Piramal India Ltd. had informed the Exchange that the Register of Members and Share Transfer Books (equity shares) would be closed from July 01, 2005 to July 07, 2005 for the purpose of ascertaining the entitlement of shareholders to receive dividends to be declared at the AGM. The Company has now informed the Exchange that the company has decided to fix the said book closure period also for the purpose of determining the entitlement of the equity shareholders to subscribe to the equity shares under the Rights Issue. Therefore the said book closure period would be for the combined pur

Nicholas Piramal India Ltd. had informed the Exchange of the decision of the BOD's of the Company to raise funds by a Rights Issue of Equity Shares to the shareholders of the Company of an amount not exceeding Rs.3,500 million and that the Board had at that meeting constituted a Committee of Directors for the purpose of taking various decision in connection with the said Rights Issue. The Company has now informed that at the meeting of the Committee of Directors held on May 05, 2005, the Committee approved the Share Ratio for the said Rights Issue as 1:10 i.e. one Rights Equity Share of Rs.2

Nicholas Piramal India Ltd. has informed the Exchange that the BODs at its meeting held on April 26,2005 has decided to maintain the equity dividend at the previous year's level i.e. @ 150% (Rs.3/- per equity shares).The Annual General Meeting has been scheduled to be held on July 07,2005.The register of members and share transfer books would be closed from July 01,2005 to July 07,2005 for the purpose of declaration of dividend.

Nicholas Piramal India Ltd. has informed the Exchange that the following dividends have been recommended by the board at its meeting held on April 26,2005:1)Preference dividend @ 6% on the 15,00,000 Redeemable Preference Shares of Rs.100/- each;2)Preference Dividend @ 5% on the 15,00,000 Redeemable Preference Shares of Rs.100/- each and 3)Preference dividend @ 5% on the 2,33,72,280 Redeemable Preference Shares of Rs.10/- each. The company has further informed that increase in the FII/NRI Investment limit subject to an overall cap of 49% in the equity share capital of the company, subject to sh

Nicholas Piramal India Ltd. has informed the Exchange that the company has submitted IND to Canadian regulators for Phase-1 clinical trials for its oncology lead molecule P-276-00. The details of the press release issued by the Company regarding the Audited Results for the FY ended March 31, 2005 and the commencement of clinical trials aforesaid shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Nicholas Piramal India Ltd. has informed the Exchange that Mr. Rajesh Laddha has sold 10,000 shares of Nicholas Piramal India Limited on April 05, 2005 .The shareholding of Mr. Rajesh Laddha after the said sale is Nil shares of the company.

Nicholas Piramal India Ltd. has informed the Exchange that the Company's domestic formulations sales (which at Rs.7821 million formed 77% of total stand-alone net sales till YTD December 2004) have been adversely affected due to market conditions that prevailed in January - March 2005 quarter. The main reasons for the above are : (1) Down stocking by wholesalers and retailers because of VAT coming into effect from April 01, 2005; (2) Retail Chemists' strike regarding psychotropic / narcotic drugs. On a comparative basis, the stand-alone domestic formulations net sales of the company were Rs.25

Nandan Piramal Investments Pvt. Limited (Nandan Piramal Investments Pvt. Limited is part of the Promoter Group) has informed the Exchange that they have sold 90,00,000 shares aggregating to 4.736% on February 28, 2005 and 62,72,171 shares aggregating to 3.301% on March 01, 2005, of the total paid up capital of Nicholas Piramal India Limited. The mode of sale is Off Market and the shareholding of Nandan Piramal Investments Pvt. Limited after the said sale is 805,614 shares aggregating to 0.424% of the total paid up capital of Nicholas Piramal India Limited.

Nicholas Piramal India Ltd. has informed the Exchange that Board of Directors of the Company at their meeting held on March 12, 2005 have decided to raise funds not exceeding Rs. 3,500 million through issue of equity shares on rights basis. The Board has constituted a Committee of Directors and delegated powers to the Committee to do all such acts and deeds as may be required to work out the modalities and other procedural matters with regard to the proposed Rights issue. The Committee is authorized to inter-alia determine the final size of the Rights issue, the price band per share prior to

Piramal Polymers Limited(Piramal Polymers Limited is part of the promoter group) has informed the Exchange that they have acquired 62,72,171 shares aggregating to 3.301% of the total paid up capital of Nicholas Piramal India Limited on March 01,2005.The mode of acquisition is through Inter se Transfer and the shareholding of Piramal Polymers Limited after the said acquisition is 1,55,22,846* shares aggregating to 8.169% of the total paid up capital of the company. *Includes 90,00,000 shares acquired on February 28,2005 by inter se transfer mode.

Piramal Polymers Limited (Piramal Polymers Limited is part of the promoter group) has informed the Exchange that they have acquired 90,00,000 shares aggregating to 4.736% of the total paid up capital of Nicholas Piramal India Limited on February 28,2005.The mode of acquisition is through Inter se Transfer and the shareholding of Piramal Polymers Limited after the said acquisition is 92,50,675 shares aggregating to 4.868% of the total paid up capital of the company.

Nicholas Piramal India Ltd. has informed the Exchange that Piramal Polymers Limited (Piramal Polymers Limited is part of the Promoter Group), have acquired 90,00,000 shares aggregating to 4.736% of the total paid up capital of Nicholas Piramal India Limited. The date of acquisition is February 28, 2005 and the mode of acquisition is through Inter se Transfer. The shareholding of Piramal Polymers Limited after the said acquisition is 92,50,675 shares aggregating to 4.868% of the total paid up capital of Nicholas Piramal India Limited.

Nicholas Piramal India Ltd. has informed the Exchange that Piramal Polymers Limited (Piramal Polymers Limited is part of the Promoter Group), have acquired 62,72,171 shares aggregating to 3.301% of the total paid up capital of Nicholas Piramal India Limited. The date of acquisition is March 01, 2005 and the mode of acquisition is through Inter se Transfer. The shareholding of Piramal Polymers Limited after the said acquisition is 1,55,22,846 shares aggregating to 8.169% of the total paid up capital of Nicholas Piramal India Limited.